Please Download Flash

Browse News by Year:
RSS  RSS

 

Intranasal Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran
Send To a Colleague Send To a Colleague Send To a Colleague
Send To a Colleague
Print Printable Version
Email To a Colleague Send to a Colleague
Send To a Colleague
Send To a Colleague Send To a Colleague Send To a Colleague

Montvale, NJ and Lexington, KY, April 4, 2007 -

Intranasal Therapeutics, Inc. (ITI), a specialty pharmaceutical company focused on developing nasally delivered, preservative-free drug products, today announced the appointment of Peter F. Young as President and Chief Executive Officer. Mr. Young was most...